The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

The biosimilar will be available in both subcutaneous and intravenous formulations and has nearly all the same indications as ...

Source: Freddie Mac By The New York Times By Danielle Kaye The average rate on 30-year fixed-rate mortgages surpassed 7 percent for the first time since May, Freddie Mac reported on Thursday ...

The December Consumer Price Index report showed an acceleration in year-on-year total CPI inflation to 2.9%, the highest rate since July 2024. Meanwhile, core CPI remained sticky and elevated but ...

Economists had penciled in a 0.3% rise. Traders of interest-rate futures still see the Fed waiting until June to deliver a first rate cut, but are now pricing about even odds the central bank will ...

Wall Street is starting to come to terms with a dwindling likelihood that the Federal Reserve will continue its rate-cutting cycle this year. After a blockbuster jobs report, some expect no cuts ...

As a result, the Fed now projects a lower number of rate cuts will occur this year. The Fed rate can have an impact on the rates you earn with savings accounts like certificates of deposit ...

Furthermore, if year-on-year total and core CPI inflation rates accelerate for December, financial markets could face significant turbulence as investors’ expectations for 2025 interest rate ...

The average long-term U.S. mortgage rate ticked up again this week, remaining at its highest level since July. The benchmark 30-year fixed rate loan rate rose to 6.93% from 6.91% last week ...

The average rate on the popular 30-year fixed-rate mortgage climbed to 6.93%, the highest level since early July, from 6.91% last week, mortgage finance agency Freddie Mac said on Thursday.